Search research articles
Contact Us
Filters
Showing results (151-160 of 188) with videos related to
Page
of 19
Sort By:
Neuro-Oncology
|
August 29, 2014
Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group
Brian M Alexander, Evanthia Galanis, W K Alfred Yung, et al.
Biorxiv : the Preprint Server for Biology
|
May 18, 2026
Single-Cell Atlas of Renal Cell Carcinoma Brain Metastasis Uncovers Mechanisms of Immune Dysfunction and Resistance
Mostafa I H Ali, Zeynep Feyza Akpinar, Jose A Ovando-Ricardez, et al.
Scientific Reports
|
June 11, 2016
IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation
Yavuz Oktay, Ege Ülgen, Özge Can, et al.
JCI Insight
|
March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression
Hinda Najem, Martina Ott, Cynthia Kassab, et al.
Biorxiv : the Preprint Server for Biology
|
May 3, 2023
Interplay between <i>ATRX</i> and <i>IDH1</i> mutations governs innate immune responses in diffuse gliomas
Seethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Neuro-Oncology
|
June 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
Martin J van den Bent, Pim J French, Daniel Brat, et al.
Nature Communications
|
January 25, 2024
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
Seethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients
Eudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2014
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma
Antonio Omuro, Kathryn Beal, Philip Gutin, et al.
Biorxiv : the Preprint Server for Biology
|
July 3, 2026
Multi-Omics Study of Ancestry in Adults with Intracranial Cancers - Glioma (MOSAIC)
Melissa L Bondy, Humaira Noor, Spiridon Tsavachidis, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 188) with videos related to
Sort By:
Page
of 19
Neuro-Oncology
|
August 29, 2014
Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group
Brian M Alexander, Evanthia Galanis, W K Alfred Yung, et al.
Biorxiv : the Preprint Server for Biology
|
May 18, 2026
Single-Cell Atlas of Renal Cell Carcinoma Brain Metastasis Uncovers Mechanisms of Immune Dysfunction and Resistance
Mostafa I H Ali, Zeynep Feyza Akpinar, Jose A Ovando-Ricardez, et al.
Scientific Reports
|
June 11, 2016
IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation
Yavuz Oktay, Ege Ülgen, Özge Can, et al.
JCI Insight
|
March 22, 2022
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression
Hinda Najem, Martina Ott, Cynthia Kassab, et al.
Biorxiv : the Preprint Server for Biology
|
May 3, 2023
Interplay between <i>ATRX</i> and <i>IDH1</i> mutations governs innate immune responses in diffuse gliomas
Seethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Neuro-Oncology
|
June 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
Martin J van den Bent, Pim J French, Daniel Brat, et al.
Nature Communications
|
January 25, 2024
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
Seethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 26, 2015
A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients
Eudocia Q Lee, Thomas J Kaley, Dan G Duda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 10, 2014
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma
Antonio Omuro, Kathryn Beal, Philip Gutin, et al.
Biorxiv : the Preprint Server for Biology
|
July 3, 2026
Multi-Omics Study of Ancestry in Adults with Intracranial Cancers - Glioma (MOSAIC)
Melissa L Bondy, Humaira Noor, Spiridon Tsavachidis, et al.
Page
of 19